Cargando...
Dihydrofolate Reductase Is a Valid Target for Antifungal Development in the Human Pathogen Candida albicans
While the folate biosynthetic pathway has provided a rich source of antibacterial, antiprotozoal, and anticancer therapies, it has not yet been exploited to develop uniquely antifungal agents. Although there have been attempts to develop fungal-specific inhibitors of dihydrofolate reductase (DHFR),...
Gardado en:
| Publicado en: | mSphere |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Microbiology
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7316490/ https://ncbi.nlm.nih.gov/pubmed/32581079 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/mSphere.00374-20 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|